TREM2 and metabolic dysfunction-associated steatotic liver disease: The expression of the triggering receptor expressed on myeloid cells 2 (Trem2) gene, which has previously been shown to have protective effects against NAFLD progression in a mouse model48,49, was upregulated in HFD-fed KD mice compared to that in HFD-fed CON mice (Fig. 7F, G).